EE429 Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.812
https://www.valueinhealthjournal.com/article/S1098-3015(25)03369-8/fulltext
Title :
EE429 Estimation of Utility Weights for Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Previously Treated with a Covalent Bruton Kinase Inhibitor (cBTKi)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03369-8&doi=10.1016/j.jval.2025.09.812
First page :
Section Title :
Open access? :
No
Section Order :
10377